Oramed Pharmaceuticals
ORMP
#8770
Rank
S$0.12 B
Marketcap
$3.15
Share price
3.02%
Change (1 day)
19.47%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): S$33.72 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of S$9.39 Million, an increase over its 2022 earnings that were of -S$48.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$33.72 M259.08%
2023 S$9.39 M-119.45%
2022 -S$48.29 Million39.17%
2021 -S$34.7 Million73.93%
2020 -S$19.95 Million18.53%
2019 -S$16.83 Million-16.62%
2018 -S$20.19 Million38.32%
2017 -S$14.6 Million12.51%
2016 -S$12.97 Million25.01%
2015 -S$10.38 Million18.18%
2014 -S$8.78 Million39.72%
2013 -S$6.29 Million46.4%
2012 -S$4.3 Million128.32%
2011 -S$1.88 Million-51.47%
2010 -S$3.88 Million35.21%
2009 -S$2.87 Million
2007 -S$4.51 Million607.04%
2006 -S$0.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.69 Billion-2,157.69%๐Ÿ‡บ๐Ÿ‡ธ USA
S$22.21 B 66,581.97%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
S$9.76 B 29,210.12%๐Ÿ‡ซ๐Ÿ‡ท France
-S$0.68 Million-102.01%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-S$0.27 Billion-899.66%๐Ÿ‡บ๐Ÿ‡ธ USA